NCT01014429
- Conditions
- Advanced or Metastatic Solid Tumors
- Locations
-
- Arizona TGen Clinical Research Services at Scottsdale Heathcare Scottsdale, Arizona, United States
Clinical trial condition
Advanced or Metastatic Solid Tumors
Explore clinical trials studying Advanced or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.
53 public trials
17 recruiting studies
Advanced or Metastatic Solid Tumors trial results
Active, Not Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
NCT06781983
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
- Locations
-
- Massachusetts General Hospital - Boston Boston, Massachusetts, United States
- John Theurer Cancer Center Hackensack, New Jersey, United States
- Mount Sinai Tisch Cancer Center New York, United States
- NEXT Oncology - Dallas Dallas, Texas, United States
Active, Not Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
NCT05787587
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
- Locations
-
- HonorHealth Research Institute Phoenix, Arizona, United States
- The Angeles Clinic Los Angeles, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- California Pacific Medical Center San Francisco, California, United States
Active, Not Recruiting
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
NCT04866134
- Conditions
- Advanced or Metastatic Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Sarah Cannon Research Institute (HealthONE) Denver, Colorado, United States
- Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States
- Sarah Cannon Research Institute (Tennessee Oncology) Nashville, Tennessee, United States
- Mary Crowley Cancer Research Dallas, Texas, United States
NCT06074497
- Conditions
- Advanced or Metastatic Solid Tumors
- Locations
-
- Pindara Private Hospital Benowa, Queensland, Australia
- Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
- Peninsula & South Eastern Haematology and Oncology Group Frankston, Victoria, Australia
Active, Not Recruiting
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
NCT04670679
- Conditions
- Advanced or Metastatic Solid Tumors, Carcinoma, Carcinoma, Squamous Cell, +33 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Washington University St Louis, Missouri, United States
Active, Not Recruiting
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
NCT05907304
- Conditions
- Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
Active, Not Recruiting
A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma
NCT06939283
- Conditions
- Advanced or Metastatic Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
Active, Not Recruiting
A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors
NCT06548217
- Conditions
- Advanced or Metastatic Solid Tumors
- Locations
-
- National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
- Tohoku University Hospital Sendai, Miyagi, Japan
- Niigata Cancer Center Hospital Niigata, Japan
- Osaka International Cancer Institute Osaka, Japan
Active, Not Recruiting
Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors
NCT03155061
- Conditions
- Advanced or Metastatic Solid Tumors
- Locations
-
- Aichi Clinical Site 1 Nagoya, Aichi-ken, Japan
- Aichi Clinical Site 2 Toyoake, Aichi-ken, Japan
- Chiba Clinical Site 1 Kashiwa, Chiba, Japan
- Ehime Clinical Site1 Matsuyama, Ehime, Japan